Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mitogen-activated protein kinase 14 | ||
Ligand | BDBM50304013 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_595431 (CHEMBL1040072) | ||
IC50 | 211±n/a nM | ||
Citation | Koch, P; Jahns, H; Schattel, V; Goettert, M; Laufer, S Pyridinylquinoxalines and pyridinylpyridopyrazines as lead compounds for novel p38 alpha mitogen-activated protein kinase inhibitors. J Med Chem53:1128-37 (2010) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Mitogen-activated protein kinase 14 | |||
Name: | Mitogen-activated protein kinase 14 | ||
Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 41286.76 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q16539 | ||
Residue: | 360 | ||
Sequence: |
| ||
BDBM50304013 | |||
n/a | |||
Name | BDBM50304013 | ||
Synonyms: | 4-(4-(3-(4-Fluorophenyl)quinoxalin-2-yl)pyridin-2-ylamino)cyclohexanol | CHEMBL566841 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H23FN4O | ||
Mol. Mass. | 414.4747 | ||
SMILES | O[C@H]1CC[C@@H](CC1)Nc1cc(ccn1)-c1nc2ccccc2nc1-c1ccc(F)cc1 |r,wU:1.0,wD:4.7,(2.39,-45.47,;3.72,-44.7,;3.72,-43.16,;5.04,-42.39,;6.37,-43.15,;6.39,-44.69,;5.06,-45.47,;7.7,-42.38,;7.69,-40.84,;9.02,-40.06,;9.01,-38.53,;7.68,-37.76,;6.34,-38.53,;6.35,-40.07,;10.34,-37.75,;11.67,-38.51,;13,-37.75,;14.33,-38.52,;15.67,-37.75,;15.66,-36.2,;14.33,-35.43,;13,-36.21,;11.67,-35.44,;10.34,-36.2,;9,-35.44,;9,-33.89,;7.67,-33.12,;6.33,-33.89,;5,-33.13,;6.34,-35.44,;7.67,-36.2,)| | ||
Structure |